Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen".

	Organisation	Cobo Technologies ApS
	Organisation 2	Leo Pharma A/S
	Group	Leo Pharma (Group)
	Product	PIPPR® protein expression analysis platform
	Index term 2	United States (govt)–Cobo Technologies: genome editing, 201904– collab Cobo beomes member of NIST Genome Editing Consortium
	Person	Herlevsen, Hasse (Cobo Technologies 201904– COO + Co-Owner before Leo Pharma)

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Hasse will be responsible for the daily operation including all internal/external QC related projects. In addition he will also lead our membership in the NIST - Genome Editing Consortium and advise customers about standards and guidelines within the CRISPR Medicine field.

Record changed: 2019-07-09

Picture EasyFairs Connect in Pharma 2023 Geneva Networking 650x200px

More documents for Cobo Technologies ApS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)